Phase i study of the Plk1 inhibitor BI 2536 administered intravenously on three consecutive days in advanced solid tumours (Q35703610)
Jump to navigation
Jump to search
scientific article published on February 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase i study of the Plk1 inhibitor BI 2536 administered intravenously on three consecutive days in advanced solid tumours |
scientific article published on February 2012 |
Statements
1 reference
Phase i study of the Plk1 inhibitor BI 2536 administered intravenously on three consecutive days in advanced solid tumours (English)
1 reference
A Frost
1 reference
K Mross
1 reference
S Steinbild
1 reference
S Hedbom
1 reference
C Unger
1 reference
R Kaiser
1 reference
D Trommeshauser
1 reference
G Munzert
1 reference
1 February 2012
1 reference
1 reference
19
1 reference
1
1 reference
e28-35
1 reference
1 February 2012
1 reference
Identifiers
1 reference
1 reference
1 reference